Is rat liver affected by non-alcoholic steatosis more susceptible to the acute toxic effect of thioacetamide?

International Journal of Experimental Pathology

Volumn 92, Issue 4, 2011, Pages 281-289

  Kučera, Otto ^a   Lotková, Halka ^a   Staňková, Pavla ^a   Podhola, Miroslav ^b   Roušar, Tomáš ^a,c   Mezera, Vojtěch ^a   Červinková, Zuzana ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c UNIVERSITY OF PARDUBICE   (Czech Republic)

Author keywords

Cytokines; Fatty liver; Hepatotoxicity; Oxidative stress; Thioacetamide

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; FAT; GLUCOSE; GLUTATHIONE; INTERLEUKIN 6; THIOACETAMIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CALORIC INTAKE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE PREDISPOSITION; FAT INTAKE; GLUCOSE BLOOD LEVEL; HEPATITIS; HISTOPATHOLOGY; LIVER LEVEL; LIVER MITOCHONDRION; LIVER NECROSIS; LIVER REGENERATION; LIVER TOXICITY; MALE; MITOCHONDRIAL RESPIRATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; UREA BLOOD LEVEL;

EID: 79959895417     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2011.00765.x     Document Type: Article

References (42)

1. Apte U.M., Limaye P.B., Ramaiah S.K. et al. (2002) Upregulated promitogenic signaling via cytokines and growth factors: potential mechanism of robust liver tissue repair in calorie-restricted rats upon toxic challenge. Toxicol. Sci. 69, 448-459.
2. Avni Y., Shirin H., Aeed H., Shahmurov M., Birkenfeld S., Bruck R. (2004) Thioacetamide-induced hepatic damage in a rat nutritional model of steatohepatitis. Hepatol. Res. 30, 141-147.
3. Bélanger M. & Butterworth R.F. (2005) Acute liver failure: a critical appraisal of available animal models. Metab. Brain Dis. 20, 409-423.
4. Bligh E.G. & Dyer W.J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917.
5. Bustamante E., Soper J.W., Pedersen P.L. (1977) A high-yield preparative method for isolation of rat liver mitochondria. Anal. Biochem. 80, 401-408.
6. Caballero M.E., Berlanga J., Ramirez D. et al. (2001) Epidermal growth factor reduces multiorgan failure induced by thioacetamide. Gut 48, 34-40.
7. Červinková Z. & Drahota Z. (1998) Enteral administration of lipid emulsions protects liver cytochrome c oxidase from hepatotoxic action of thioacetamide. Physiol. Res. 47, 151-154.
8. Červinková Z., Rauchová H., Křiváková P., Drahota Z. (2008) Inhibition of palmityl carnitine oxidation in rat liver mitochondria by tert-butyl hydroperoxide. Physiol. Res. 2008, 133-136.
9. Chen T.M., Subeq Y.M., Lee R.P., Chiou T.W., Hsu B.G. (2008) Single dose intravenous thioacetamide administration as a model of acute liver damage in rats. Int. J. Exp. Pathol. 89, 223-231.
10. Chilakapati J., Shankar K., Korrapati M.C., Hill R.A., Mehendale H.M. (2005) Saturation toxicokinetics of thioacetamide: role in initiation of liver injury. Drug Metab. Dispos. 33, 1877-1885.
11. Chilakapati J., Korrapati M.C., Hill R.A., Warbritton A., Latendresse J.R., Mehendale H.M. (2007) Toxicokinetics and toxicity of thioacetamide sulfoxide: a metabolite of thioacetamide. Toxicology 230, 105-116.
12. Chitturi S., Abeygunasekera S., Farrell G.C. et al. (2002) NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35, 373-379.
13. Drahota Z., Křiváková P., Červinková Z. et al. (2005) Tert-butyl hydroperoxide selectively inhibits mitochondrial respiratory-chain enzymes in isolated rat hepatocytes. Physiol. Res. 54, 67-72.
14. Fausto N., Campbell J.S., Riehle K.J. (2006) Liver regeneration. Hepatology 43, S45-S53.
15. Gambino R., Musso G., Cassader M. (2010) Redox balance in the pathogenesis of non-alcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxid. Redox Signal. doi:.
16. Hissin P.J. & Hilf R. (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74, 214-226.
17. Kand'ár R., Žáková P., Lotková H., Kučera O., Červinková Z. (2007) Determination of reduced and oxidized glutathione in biological samples using liquid chromatography with fluorimetric detection. J. Pharm. Biomed. Anal. 43, 1382-1387.
18. Kanzler S., Lohse A.W., Keil A. et al. (1999) TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am. J. Physiol. 276, G1059-G1068.
19. Knittel T., Mehde M., Kobold D., Saile B., Dinter C., Ramadori G. (1999) Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J. Hepatol. 30, 48-60.
20. Kovalovich K., DeAngelis R.A., Li W., Furth E.E., Ciliberto G., Taub R. (2000) Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 31, 149-159.
21. Kučera O., Garnol T., Lotková H. et al. (2011) The effect of rat strain, diet composition and feeding period on the development of a nutritional model of non-alcoholic fatty liver disease in rats. Physiol. Res. ().
22. Lieber C.S., Leo M.A., Mak K.M. et al. (2004) Model of nonalcoholic steatohepatitis. Am. J. Clin. Nutr. 79, 502-509.
23. Lotková H., Červinková Z., Kučera O., Roušar T., Křiváková P. (2007) S-adenosylmethionine exerts a protective effect against thioacetamide-induced injury in primary cultures of rat hepatocytes. Altern. Lab. Anim. 35, 363-371.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
25. Mangipudy R.S., Chanda S., Mehendale H.M. (1995) Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Environ. Health Perspect. 103, 260-267.
26. Natarajan S.K., Thomas S., Ramamoorthy P. et al. (2006) Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models. J. Gastroenterol. Hepatol. 21, 947-957.
27. Okhawa H., Ohishi N., Yagi K. (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358.
28. Okuyama H., Nakamura H., Shimahara Y. et al. (2003) Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice. Hepatology 37, 1015-1025.
29. Pallottini V., Martini C., Bassi A.M. et al. (2006) Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species content. J. Hepatol. 44, 368-374.
30. Plumpe J., Malek N.P., Bock C.T., Rakemann T., Manns M.P., Trautwein C. (2000) NF-kB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am. J. Physiol. Gastrointest. Liver Physiol. 278, G173-G183.
31. Rahman T.M. & Hodgson H.J. (2000) Animal models of acute hepatic failure. Int. J. Exp. Pathol. 81, 145-157.
32. Sanz N., Díez-Fernández C., Andrés D., Cascales M. (2002) Hepatotoxicity and aging: endogenous antioxidant systems in hepatocytes from 2-, 6-, 12-, 18- and 30-month-old rats following a necrogenic dose of thioacetamide. Biochim. Biophys. Acta 1587, 12-20.
33. Shankar K., Vaidya V.S., Wang T., Bucci T.J., Mehendale H.M. (2003) Streptozotocin-induced diabetic mice are resistant to lethal effects of thioacetamide hepatotoxicity. Toxicol. Appl. Pharmacol. 188, 122-134.
34. Shapiro H., Ashkenazi M., Weizman N., Shahmurov M., Aeed H., Bruck R. (2006) Curcumin ameliorates acute thioacetamide-induced hepatotoxicity. J. Gastroenterol. Hepatol. 21, 358-366.
35. Staňková P., Kučera O., Lotková H., Roušar T., Endlicher R., Červinková Z. (2010) The toxic effect of thioacetamide on rat liver in vitro. Toxicol. In Vitro 24, 2097-3103.
36. Svátková R., Červinková Z., Kalous M., Rauchová H., Drahota Z. (1996) Respiratory control index of mitochondria isolated from regenerating rat liver. Physiol. Res. 45, 249-252.
37. Tarantino G., Savastano S., Colao A. (2010) Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J. Gastroenterol. 16, 4773-4783.
38. Vendemiale G., Grattagliano I., Caraceni P. et al. (2001) Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status. Hepatology 33, 808-815.
39. Videla L.A., Rodrigo R., Orellana M. et al. (2004) Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin. Sci. (Lond). 106, 261-268.
40. Wang T., Fontenot R.D., Soni M.G., Bucci T.J., Mehendale H.M. (2000) Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats. Toxicol. Appl. Pharmacol. 166, 92-100.
41. Wu G., Fang Y.Z., Yang S., Lupton J.R., Turner N.D. (2004) Glutathione metabolism and its implications for health. J. Nutr. 134, 489-492.
42. Zou Y., Li J., Lu C. et al. (2006) High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci. 79, 1100-1107.